Effect of budesonide / formoterol combination in repeated AMP provocations
Study identifier:BN-00S-0022
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A randomized double blind comparison between single doses of Symbicort Turbuhaler (budesonide/formoterol combination), formoterol, salbutamol and placebo in repeated AMP-challenges in patients with mild - to moderate asthma. Investigating the supplementary value of the budesonide component within Symbicort when tested in a model of slow onset acute asthma
Medical condition
asthma
Phase
Phase 4
Healthy volunteers
No
Study drug
budesonide/formoterol Turbuhaler, formoterol Turbuhaler, salbutamol
Sex
All
Actual Enrollment
20
Study type
Interventional
Age
18 Years - 55 Years
Date
Study Start Date: 01 Apr 2004
Primary Completion Date: -
Study Completion Date: 01 Nov 2005
Study design
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Double Blind
Primary Purpose: Treatment
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
AstraZeneca Netherlands Medical Director
AstraZeneca
